$FNA News
Last published 1y ago
- 1y agoFNAParagon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual ConferenceBusiness WireParagon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American College of Foot and Ankle Surgeons
- 1y agoFNAZBHParagon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR ActBusiness WireParagon 28, Inc. (NYSE:FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of the waiting period under the
- 1y agoFNAParagon 28 to Feature Several Recent Product Launches at The American Academy of Orthopaedic Surgeons Annual ConferenceBusiness WireParagon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American Academy of Orthopaedic Surgeons
- 1y agoFNAGLIARTMEI+2Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Paragon 28, Inc. (NYSE: FNA); Integra Lifesciences Holdings Corp. (NASDAQ: IART); Telephone and Data Systems, Inc. (NYSE: TDS); Methode Electronics, Inc. (NYSE: MEI); and Globe Life Inc. (NYSE: GL)GlobeNewswirePHILADELPHIA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Paragon 28, Inc. (NYSE:FNA): Grabar Law Office is actively investigating claims on behalf of shareholders of Paragon 28, Inc. (NYSE:FNA). Current shareholders who
- 1y agoFNAGLIARTMEI+2Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Globe Life Inc. (NYSE: GL); Paragon 28, Inc. (NYSE: FNA); Integra Lifesciences Holdings Corp. (NASDAQ: IART); Telephone and Data Systems, Inc. (NYSE: TDS); and Methode Electronics, Inc. (NYSE: MEI)GlobeNewswirePHILADELPHIA, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globe Life Inc. (NYSE:GL) FKA Torchmark (NYSE:TMK): Grabar Law Office is investigating claims on behalf of Globe Life Inc. (NYSE:GL) FKA Torchmark (NYSE:TMK)
- 1y agoZBHFNAZimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial ResultsPR NewswireZimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2024. The Company...
- 1y agoAVAVFNANARITGIKuehn Law Encourages FNA, TGI, AVAV, and NARI Investors to Contact Law FirmGlobeNewswireNEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 1y agoAXLDFSFNATURNKuehn Law Encourages AXL, FNA, DFS, and TURN Investors to Contact Law FirmGlobeNewswireNEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 1y agoFNAParagon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024Business WireParagon 28, Inc. (NYSE:FNA) ("Paragon 28" or "P28"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited net revenue for the
- 1y agoFNAParagon 28 to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness WireParagon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply
- 1y agoATECFNAParagon 28 Appoints Dave Demski to Board of DirectorsBusiness WireParagon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr.
- 1y agoFNAThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit – FNAGlobeNewswireNEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE:FNA). Shareholders who purchased shares of FNA during the class period listed are
- 1y agoFNAThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit - FNAPR NewswireThe Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the...
- 1y agoFNAThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 29, 2024 in Paragon 28, Inc. Lawsuit - FNAPR NewswireThe Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the...
- 1y agoFNAParagon 28, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 29, 2024 to Discuss Your Rights – FNAGlobeNewswireNEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE:FNA). Shareholders who purchased shares of FNA during the class period listed are
- 1y agoFNAParagon 28 to Present at the 36th Annual Piper Sandler Healthcare ConferenceBusiness WireParagon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO, will participate
- 1y agoFNAParagon 28, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - FNAPR NewswireThe Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the...
- 1y agoFNAINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28PR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Paragon 28, Inc. ("Paragon 28" or the...
- 1y agoFNAParagon 28, Inc (FNA) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoFNAParagon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue GuidanceBusiness WireParagon 28, Inc. (NYSE:FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended September
- 2y agoFNAINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28PR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Paragon 28, Inc. ("Paragon 28" or the...
- 2y agoFNAParagon 28, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - FNAPR NewswireThe Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the...
- 2y agoFNAINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28GlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options If you suffered
- 2y agoFNAParagon 28, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – FNAGlobeNewswireNEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE:FNA). Shareholders who purchased shares of FNA during the class period listed are
- 2y agoFNAParagon 28, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 29, 2024 to Discuss Your Rights - FNAPR NewswireThe Gross Law Firm issues the following notice to shareholders of Paragon 28, Inc. (NYSE: FNA). Shareholders who purchased shares of FNA during the...
- 2y agoFNAINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28PR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Paragon 28, Inc. ("Paragon 28" or the...
- 2y agoFNAParagon 28 To Report Third Quarter 2024 Financial Results on November 12, 2024Business WireParagon 28, Inc. (NYSE:FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the third quarter 2024 after market
- 2y agoFNAParagon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture RepairBusiness WireParagon 28, Inc. (NYSE:FNA) is pleased to announce the launch of the Phantom® Fibula Nail System, designed to give surgeons a less invasive option to treat the fibula when patients sustain an ankle fracture. Use of
- 2y agoFNAMoore Law, PLLC Encourages Paragon 28, Inc. Investors to Contact Law FirmPR NewswireMoore Law, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: Paragon 28, Inc. (NYSE:...
- 2y agoFNAParagon 28 Introduces a Novel Right-Angle Drill for the APEX 3D™ Total Ankle Replacement SystemBusiness WireParagon 28, Inc. (NYSE:FNA) is pleased to announce the addition of a novel Right-Angle Drill to the APEX 3D™ Total Ankle Replacement System designed to improve tibia preparation prior to the implantation of the
- 2y agoFNAParagon 28 Launches the R3FLEX™ Stabilization System to Anatomically Repair Ankle Syndesmotic InjuriesBusiness WireParagon 28, Inc. (NYSE:FNA), is pleased to announce the launch of the R3FLEX™ Stabilization System, which is designed to restore stability to the ankle syndesmosis after injury from an ankle fracture or high
- 2y agoFNAParagon 28 Announces the Launch of SMART 28℠ Portal and First Case Using SMART Bun-Yo-Matic℠Business WireParagon 28, Inc. (NYSE:FNA), is proud to announce the launch of the SMART28℠ Case Management Portal, a cutting-edge platform that leverages AI and a seamless user experience to coordinate patient-specific surgical
- 2y agoFNAParagon 28, Inc. (FNA) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoFNAParagon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue GuidanceBusiness WireParagon 28, Inc. (NYSE:FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Chadi Chahine has been appointed Chief
- 2y agoFNAKirby McInerney LLP Announces Investigation of Shareholder Claims Against Paragon 28, Inc. (FNA)Business WireThe law firm of Kirby McInerney LLP is investigating potential claims against Paragon 28, Inc. ("Paragon 28" or the "Company") (NYSE:FNA). The investigation concerns whether Paragon 28 and/or certain of its officers
- 2y agoFNAParagon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024Business WireParagon 28, Inc. (NYSE:FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market
- 2y agoFNAParagon 28, Inc. (FNA) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoFNAParagon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue GuidanceBusiness WireParagon 28, Inc. (NYSE:FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended March 31,
- 2y agoFNAParagon 28 to Present at the Bank of America Securities 2024 Healthcare ConferenceBusiness WireParagon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will
- 2y agoFNAAppointment of Stephen M. Deitsch as new Chief Financial OfficerGlobeNewswireOXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx, a medical device company which is changing the paradigm in liver transplantation in the US and Europe with its groundbreaking normothermic machine
- 2y agoFNAParagon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024Business WireStephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial Officer Preliminary, unaudited first quarter 2024 net revenue
- 2y agoFNAParagon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair SystemBusiness WireParagon 28, Inc. (NYSE:FNA), is pleased to announce the launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the
- 2y agoFNAParagon 28, Inc. (FNA) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoFNAParagon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue GuidanceBusiness WireParagon 28, Inc. (NYSE:FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and year ended
- 2y agoFNAParagon 28 to Present at the CG 2024 Musculoskeletal ConferenceBusiness WireParagon 28, Inc. (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in
- 2y agoFNAParagon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024Business WireParagon 28, Inc. (NYSE:FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the fourth quarter and full year 2023
- 2y agoFNAParagon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with BunionsBusiness WireParagon 28, Inc. (NYSE:FNA) is pleased to announce the launch of the PRECISION® MIS Bunion System, which allows surgeons to complete a distal metatarsal osteotomy using a minimally invasive (MIS) surgical
- 2y agoFNAParagon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle ProceduresBusiness WireParagon 28, Inc. (NYSE:FNA) is proud to announce a novel solution in modernizing foot and ankle surgery with the launch of its FJ2000™ Power Console and Burr System designed for a wide range of minimally invasive
- 2y agoFNAParagon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer ProceduresBusiness WireParagon 28, Inc. (NYSE:FNA), is pleased to announce the launch of the Mister Tendon™ System which allows surgeons to perform a distal cut of the flexor hallucis longus ("FHL") or flexor digitorum longus ("FDL")
- 2y agoFNAParagon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion ProceduresBusiness WireParagon 28, Inc. (NYSE:FNA), is excited to announce the limited market release of its Bun-Yo-Matic™ Lapidus Clamp System and completion of the first surgical cases in Orange County, California and Seattle,